ERG Monoclonal Antibody in the Diagnosis and Biological Stratification of Prostate Cancer: Delineation of Minimal Epitope, Critical Residues for Binding, and Molecular Basis of Specificity-Reference-Cited by-同舟云学术

ERG Monoclonal Antibody in the Diagnosis and Biological Stratification of Prostate Cancer: Delineation of Minimal Epitope, Critical Residues for Binding, and Molecular Basis of Specificity

Published:2014-08 Issue:4 Volume:33 Page:201-208
ISSN:2167-9436
Container-title:Monoclonal Antibodies in Immunodiagnosis and Immunotherapy
language:en
Short-container-title:Monoclonal Antibodies in Immunodiagnosis and Immunotherapy

Author:

Rastogi Anshu¹,Tan Shyh-Han¹,Banerjee Sreedatta¹,Sharad Shashwat¹,Kagan Jacob²,Srivastava Sudhir²,McLeod David G.¹³,Srivastava Shiv¹,Srinivasan Alagarsamy¹

Affiliation:

1. Center for Prostate Disease Research, Department of Surgery, Uniformed Services University of the Health Sciences, Bethesda, Maryland.

2. Cancer Biomarkers Research Group, Division of Cancer Prevention, National Cancer Institute, Bethesda, Maryland.

3. Urology Service, Walter Reed National Military Medical Center, Bethesda, Maryland.

Publisher

Mary Ann Liebert Inc

Subject

Immunology,Immunology and Allergy

Link

http://www.liebertpub.com/doi/pdf/10.1089/mab.2014.0026

Reference20 articles.

1. Beyond PSA: The Next Generation of Prostate Cancer Biomarkers